These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [High-dose intravenous diethylstilbestrol diphosphate therapy for hormone refractory prostate cancer]. Honda M; Umeda H; Yoshida K Nihon Rinsho; 1998 Aug; 56(8):2145-9. PubMed ID: 9750524 [No Abstract] [Full Text] [Related]
3. A case of prostate cancer with a large abdominal mass effectively treated with a high dose of diethylstilbestrol-diphosphate. Wakisaka M; Takagishi H Hinyokika Kiyo; 1993 Sep; 39(9):849-51. PubMed ID: 8213382 [TBL] [Abstract][Full Text] [Related]
4. [A case of prostate cancer treated with combined androgen-blockade]. Kurita M; Kato Y; Tamura Y; Suzuki K; Yamanaka H Gan To Kagaku Ryoho; 2000 Feb; 27(2):307-10. PubMed ID: 10700907 [TBL] [Abstract][Full Text] [Related]
5. Cytotoxicity and metabolism of E-DES-diphosphate. Oelschläger H; Rothley D; Dunzendorfer U Prog Clin Biol Res; 1989; 303():187-95. PubMed ID: 2780647 [No Abstract] [Full Text] [Related]
6. [Drug therapy of metastasizing prostate carcinoma with special reference to the bioavailability of fosfestrol after oral administration]. Oelschläger H; Rothley D; Dunzendorfer U Arzneimittelforschung; 1988 Oct; 38(10):1502-12. PubMed ID: 3058134 [TBL] [Abstract][Full Text] [Related]
7. Histological effects of endocrine therapy for prostatic cancer in relation to clinical course. Isaka S; Teshima S; Akakura K; Igarashi T; Murakami S; Shimazaki J Jpn J Clin Oncol; 1989 Sep; 19(3):258-64. PubMed ID: 2554026 [TBL] [Abstract][Full Text] [Related]
8. [Our experience in palliative treatment of certain prostatic cancers by high-dosage estrogens combined with corticotherapy]. Neveu J; Soton G; Roche G; Cisterne JP J Urol Nephrol (Paris); 1977; 83(1-2):143-5. PubMed ID: 875120 [No Abstract] [Full Text] [Related]
9. [Revaluation of estrogen therapy on prostate cancer]. Takezawa Y; Kobayashi M; Yamanaka H Nihon Rinsho; 2000 Jul; 58 Suppl():223-7. PubMed ID: 11022718 [No Abstract] [Full Text] [Related]
10. [Hormonodependence and hormonotherapy in cancer of the prostate (author's transl)]. Juret P; Alperine G J Radiol Electrol Med Nucl; 1974 Nov; 55(11):802-4. PubMed ID: 4452960 [No Abstract] [Full Text] [Related]
11. [A case of giant prostate cancer]. Fujimoto Y; Yamaha M; Maeda S; Takeuchi T; Ito Y; Kuriyama M; Ban Y; Nishiura T Hinyokika Kiyo; 1984 Jul; 30(7):925-30. PubMed ID: 6542303 [TBL] [Abstract][Full Text] [Related]
12. Endocrine factors in the treatment of prostatic cancer. Pierrepoint CG; Turkes AO; Walker KJ; Harper ME; Wilson DW; Peeling WB; Griffiths K Prog Clin Biol Res; 1985; 185A():51-72. PubMed ID: 3162177 [No Abstract] [Full Text] [Related]
14. High-dose diethylstilbestrol diphosphate therapy of prostatic cancer after failure of standard doses of estrogens. Band PR; Banerjee TK; Patwardhan VC; Eid TC Can Med Assoc J; 1973 Oct; 109(8):697-9. PubMed ID: 4746128 [TBL] [Abstract][Full Text] [Related]
15. Hormone therapy in prostatic cancer. Smith PH; Akdas A; Mason MK; Richards B; Robinson MR; de Pauw M; Sylvester R Acta Urol Belg; 1980 Jan; 48(1):98-105. PubMed ID: 7001876 [No Abstract] [Full Text] [Related]
16. Diethylstilbestrol-diphosphate-induced disseminated intravascular coagulation in prostatic carcinoma. Cornfield DB; Rossman RE South Med J; 1982 Feb; 75(2):248-9. PubMed ID: 7058376 [No Abstract] [Full Text] [Related]
17. [Orbital metastasis of a prostatic cancer. A therapeutic emergency]. Aubert J; Dore B; Bon D Prog Urol; 1997 Feb; 7(1):81-4. PubMed ID: 9116744 [TBL] [Abstract][Full Text] [Related]